WO2020051055A3 - Cannabinoid and menthol gum and lozenge compositions and methods - Google Patents

Cannabinoid and menthol gum and lozenge compositions and methods Download PDF

Info

Publication number
WO2020051055A3
WO2020051055A3 PCT/US2019/048740 US2019048740W WO2020051055A3 WO 2020051055 A3 WO2020051055 A3 WO 2020051055A3 US 2019048740 W US2019048740 W US 2019048740W WO 2020051055 A3 WO2020051055 A3 WO 2020051055A3
Authority
WO
WIPO (PCT)
Prior art keywords
lozenge
menthol
cannabinoid
chewing gum
methods
Prior art date
Application number
PCT/US2019/048740
Other languages
French (fr)
Other versions
WO2020051055A2 (en
Inventor
Babak Ghalili
Original Assignee
Babak Ghalili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Babak Ghalili filed Critical Babak Ghalili
Publication of WO2020051055A2 publication Critical patent/WO2020051055A2/en
Publication of WO2020051055A3 publication Critical patent/WO2020051055A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6943—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a pill, a tablet, a lozenge or a capsule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)

Abstract

The present disclosure relates to chewing gum or lozenge with cannabinoids and menthol including a liquid-filled chewing gum or lozenge with a chewing gum base shell or lozenge candy shell enclosing an internal void therein and a liquid filling in the void, the liquid-filled chewing gum or lozenge including cannabinoids and menthol.
PCT/US2019/048740 2018-09-04 2019-08-29 Cannabinoid and menthol gum and lozenge compositions and methods WO2020051055A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862726713P 2018-09-04 2018-09-04
US62/726,713 2018-09-04
US201962869121P 2019-07-01 2019-07-01
US62/869,121 2019-07-01

Publications (2)

Publication Number Publication Date
WO2020051055A2 WO2020051055A2 (en) 2020-03-12
WO2020051055A3 true WO2020051055A3 (en) 2020-07-23

Family

ID=69639497

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2019/048740 WO2020051055A2 (en) 2018-09-04 2019-08-29 Cannabinoid and menthol gum and lozenge compositions and methods

Country Status (2)

Country Link
US (1) US20200069638A1 (en)
WO (1) WO2020051055A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11596618B2 (en) * 2020-01-15 2023-03-07 Resurgent Biosciences, Inc. Oral cannabinoid delivery formulations with mouthfeel experience enhancers
WO2023031922A1 (en) * 2021-08-29 2023-03-09 Ariel Scientific Innovations Ltd. Combinations of cannabis and plant-derived compounds as anti-cell proliferation-related disease agents

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050002993A1 (en) * 2003-05-02 2005-01-06 Goggin Paul Laurence Confectionery products for delivery of pharmaceutically active agents to the throat
US20110097283A1 (en) * 2008-03-26 2011-04-28 Mareda Holding Bv Chewing gum compositions comprising cannabinoids
WO2014159688A1 (en) * 2013-03-14 2014-10-02 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
US20180110730A1 (en) * 2016-10-20 2018-04-26 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and opioid agonists and/or antagonists

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050002993A1 (en) * 2003-05-02 2005-01-06 Goggin Paul Laurence Confectionery products for delivery of pharmaceutically active agents to the throat
US20110097283A1 (en) * 2008-03-26 2011-04-28 Mareda Holding Bv Chewing gum compositions comprising cannabinoids
WO2014159688A1 (en) * 2013-03-14 2014-10-02 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
US20180110730A1 (en) * 2016-10-20 2018-04-26 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and opioid agonists and/or antagonists

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Selhub . Will This Hemp-Based Oil Replace Opioids & OTC Pain Relievers", MINDBODYGREEN, 1 November 2011 (2011-11-01), Retrieved from the Internet <URL:https://www.mindbodygreen.com/articles/hemp-oil-for-pain> *
CANCHEW . NUTRACEUTICALS, 2019, Retrieved from the Internet <URL:https://aximbiotech.com/nutraceuticals> [retrieved on 20191230] *

Also Published As

Publication number Publication date
US20200069638A1 (en) 2020-03-05
WO2020051055A2 (en) 2020-03-12

Similar Documents

Publication Publication Date Title
MX2018009076A (en) Allulose-containing syrup composition and food containing same.
MX2017012877A (en) Multicomponent gummy compositions with soft core.
WO2016094810A3 (en) Microencapsulated cannabinoid compositions
WO2020051055A3 (en) Cannabinoid and menthol gum and lozenge compositions and methods
AR066593A1 (en) DISPENSING DEVICE
CO6761363A2 (en) Chocolate dough
BR112015030268A2 (en) pharmaceutical composition, container, kit, and method for preparing a composition
UY36131A (en) DISPENSED CONTAINER IN CAPSULE FORM
BRPI0506779A (en) Ice cream formulation and ice cream
MX2018003585A (en) Chewing gums containing allulose.
CR8371A (en) DRUG FORMULATIONS CONTAINING FLAVORS WITH BETTER PHARMACEUTICAL PROPERTIES
NZ712012A (en) Pertuzumab variants and evaluation thereof
BR112015020556A2 (en) transparent and translucent bullet filled with liquid; manufacturing process thereof; sugar free liquid edible composition; and use of a composition
MY176435A (en) Ndbr with molar mass breakdown
AR066595A1 (en) DISPENSING DEVICE
MX2016002787A (en) Chewing gum composition comprising a micro-encapsulated flavour in a matrix comprising protein.
EA201591302A1 (en) NON-CRIOSOGENOUS GELERY CONFECTIONERY
AR066592A1 (en) DISPENSING DEVICE
AR056040A1 (en) PACKAGE TO MARKET VISIBLY VARIATIONS DIFFERENT FROM AN EDIBLE PRODUCT
ATE432615T1 (en) CONFECTIVE PRODUCT
AR066591A1 (en) DISPENSING DEVICE
CL2016000047A1 (en) Confectionery products based on fat.
UY30065A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE ERADICATION OF HELICOBACTER PYLORI
PH12018500414A1 (en) Air cavity package
AR066588A1 (en) DISPENSING DEVICES

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19858313

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19858313

Country of ref document: EP

Kind code of ref document: A2